The Eton Pharmaceuticals Rally: A Cautionary Tale of Overexuberance The stock market can be a cruel mistress.
Just when investors think they've found a winner, it turns out to be a fleeting darling that's due for a correction. Eton Pharmaceuticals (ETON) is the latest example of this phenomenon.
The company's impressive second quarter earnings and revenue growth have sent its stock soaring to new heights, but beneath the surface lies a complex web of risks and warning signs.